Orexigen Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Orexigen Therapeutics, Inc.
CIK #0001278906, 0001382911
EDGAR Form CIK 2011 - 2025
SC 13G [0001278906]
10-K [0001382911]
10-Q [0001382911]
3 [0001382911]
4 [0001382911]
8-K [0001382911]
D [0001382911]
SC 13D [0001382911]
SC 13G [0001382911]
Form 13D/13G Filer Form 13D/13G Subject Filed
UBS OConnor LLC Orexigen Therapeutics Inc [2018-02-13]
Nineteen77 Global Multi-Strategy Alpha Master Ltd Orexigen Therapeutics Inc [2018-02-12]
Man Group PLC Orexigen Therapeutics Inc [2017-12-01]
Telemetry Investments LLC Orexigen Therapeutics Inc [2017-08-03]
Biotechnology Value Fund L P Orexigen Therapeutics Inc [2016-07-19]
Baupost Group LLC/MA Orexigen Therapeutics Inc [2016-03-24]
Baupost Group LLC/MA Orexigen Therapeutics Inc [2015-10-09]
Foresite Capital Fund III LP Orexigen Therapeutics Inc [2015-08-04]
Price T Rowe Associates Inc /MD/ Orexigen Therapeutics Inc [2015-02-12]
FMR LLC Orexigen Therapeutics Inc [2014-02-14]
Partner Fund Management LP Orexigen Therapeutics Inc [2013-12-13]
BlackRock Inc Orexigen Therapeutics Inc [2013-01-30]
Capital Research Global Investors Orexigen Therapeutics Inc [2012-11-08]
First Manhattan Co Orexigen Therapeutics Inc [2012-02-14]
[2012-02-14]
FMR LLC Orexigen Therapeutics Inc [2012-02-14]
First Manhattan Co Orexigen Therapeutics Inc [2012-02-06]
Form 3/4/5 Subject 2011 - 2025
Klarman Seth A
Orexigen Therapeutics, Inc.
Baupost Group GP, L.L.C.
Baupost Group LLC/MA
Moglia Stephen A.
Forbes Monica
Narachi Michael
Cannell Thomas R
Flynn Peter D
Keyes Jason A
View All
Terms | Privacy | Guide
tony@aum13f.com